Inge Marie Svane

Publikation

Publikationer pr. år 2003 2010 2011 2012 2013 2015 2016 2017 2018 2019 2019

• 140 Tidsskriftartikel
• 9 Review
• 5 Kommentar/debat
• 4 Bidrag til bog/antologi
• 6 Mere
  • 3 Konferenceabstrakt i tidsskrift
  • 2 Letter
  • 1 Konferenceabstrakt til konference

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2013

  Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells

  Cathelin, D., Met, Ö. & Svane, I. M., jun. 2013, I: Cytotherapy. 15, 6, s. 740-749 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Leucine Zippers 100%
  • Glucocorticoids 68%
  • Dendritic Cells 67%
  • Small Interfering RNA 21%
  • B7-H1 Antigen 19%
  8 Citationer (Scopus)

• The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

  Munir, S., Andersen, G. H., Svane, I. M. & Andersen, M. H., apr. 2013, I: OncoImmunology. 2, 4, 9 s., e23991.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • B7-H1 Antigen 100%
  • T-Lymphocytes 39%
  • HLA-A*02:01 antigen 7%
  • Cytokines 6%
  • T-Lymphocyte Epitopes 5%
  44 Citationer (Scopus)
• 2012

  Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

  Ellebaek, E., Iversen, T. Z., Junker, N., Donia, M., Engell-Noerregaard, L., Met, Ö., Hölmich, L. R., Andersen, R. S., Hadrup, S. R., Andersen, M. H., Thor Straten, P. & Svane, I. M., 21 aug. 2012, I: Journal of Translational Medicine. 10, s. 169

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Cell- and Tissue-Based Therapy 74%
  • Interleukin-2 70%
  • Melanoma 65%
  • T-Lymphocytes 18%
  102 Citationer (Scopus)

• Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

  Donia, M., Ellebaek, E., Andersen, M. H., Straten, P. T. & Svane, I. M., 2012, I: OncoImmunology. 1, 8, s. 1297-1304 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Melanoma 100%
  • Lymphocytes 83%
  • T-Lymphocytes 74%
  • Tumor-Infiltrating Lymphocytes 15%
  • Adoptive Transfer 13%
  22 Citationer (Scopus)

• A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles

  Junker, N., Munir, S., Kvistborg, P., Straten, P. T., Svane, I. M. & Andersen, M. H., aug. 2012, I: Journal of Investigative Dermatology. 132, 8, s. 2115-2118 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3 Citationer (Scopus)

• BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

  Donia, M., Fagone, P., Nicoletti, F., Andersen, R. S., Høgdall, E., Straten, P. T., Andersen, M. H. & Svane, I. M., 2012, I: OncoImmunology. 1, 9, s. 1476-1483 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Adoptive Transfer 100%
  • Melanoma 72%
  • Immune System 68%
  • T-Lymphocytes 53%
  • Vemurafenib 50%
  62 Citationer (Scopus)

• Cellular based cancer vaccines: type 1 polarization of dendritic cells

  Hansen, M., Met, O., Svane, I. M. & Andersen, M. H., sep. 2012, I: Current Medicinal Chemistry. 19, 25, s. 4239-46 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cancer Vaccines 100%
  • Cell Death 88%
  • Dendritic Cells 73%
  • Polarization 61%
  • Ligand 36%
  22 Citationer (Scopus)

• Cellular based cancer vaccines: type 1 polarization of dendritic cells

  Hansen, M., Met, Ö., Svane, I. M. & Andersen, M. H., 2012, I: Current Medicinal Chemistry. 19, 25, s. 4239-46 8 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Cancer Vaccines 100%
  • Cell Death 88%
  • Dendritic Cells 73%
  • Polarization 61%
  • Prostaglandins E 40%

• Characterization and comparison of "Standard" and "Young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution

  Donia, M., Junker, N., Ellebaek, E., Andersen, M. H., Straten, P. T. & Svane, I. M., feb. 2012, I: Scandinavian Journal of Immunology. 75, 2, s. 157-167 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Translational Medical Research 89%
  • Cell- and Tissue-Based Therapy 74%
  • Interleukin-2 12%
  • Melanoma 11%
  48 Citationer (Scopus)

• Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

  Svane, I. M., Straten, P. T., Andersen, M. H., Larsen, S. K. & Hansen, M., 26 apr. 2012, I: Cells. 1, 2, s. 51-60 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Characterization of T-cell responses against IκBα in cancer patients

  Munir, S., Frøsig, T. M., Hansen, M., Svane, I. M. & Andersen, M. H., 2012, I: OncoImmunology. 1, 8, s. 1290-1296 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T-Lymphocytes 100%
  • Cytotoxic T-Lymphocytes 87%
  • Neoplasms 52%
  • Granzymes 52%
  • Proteins 44%
  5 Citationer (Scopus)

• Comment on "Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy" by Gustav J. Ullenhag et al

  Svane, I. M., maj 2012, I: Cancer Immunology, Immunotherapy. 61, 5, s. 747; author reply 749

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Dissection of T-cell antigen specificity in human melanoma

  Andersen, R. S., Albæk Thrue, C., Junker, N., Skou, R. B. L., Donia, M., Ellebæk, E., Svane, I. M., Schumacher, T. N., Thor Straten, P. & Hadrup, S. R., 1 apr. 2012, I: Cancer Research. 72, 7, s. 1642-50 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T-Cell Antigen Receptor Specificity 100%
  • Dissection 60%
  • Melanoma 57%
  • Antigens 44%
  • T-Lymphocytes 43%
  103 Citationer (Scopus)

• Effector and regulatory T cells in patients with acute optic neuritis

  Tsakiri, A., Kjærsgaard, E., Grigoriadis, N., Svane, I. M. & Frederiksen, J. L., jan. 2012, I: Neuroimmunomodulation. 19, 2, s. 111-20 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Optic Neuritis 100%
  • Regulatory T-Lymphocytes 78%
  • T-Lymphocyte Subsets 47%
  • Multiple Sclerosis 29%
  • Cerebrospinal Fluid 29%
  3 Citationer (Scopus)

• Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

  Brimnes, M. K., Gang, A. O., Donia, M., Thor Straten, P., Svane, I. M. & Hadrup, S. R., aug. 2012, I: Cancer Immunology, Immunotherapy. 61, 8, s. 1221-31 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Adoptive Transfer 100%
  • Vaccination 69%
  • T-Lymphocytes 53%
  • In Vitro Techniques 37%
  • Neoplasms 28%
  8 Citationer (Scopus)

• IFN-γ to improve immunotherapy for melanoma

  Donia, M., Svane, I. M., Andersen, M. H., Hansen, M., Straten, P. T., Ellebæk, E., Iversen, T. Z. & SL, S., 2012. 0 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Immunotherapy for metastatic colorectal cancer: Present status and new options

  Ellebaek, E., Andersen, M. H., Svane, I. M. & Straten, P. T., mar. 2012, I: Scandinavian Journal of Gastroenterology. 47, 3, s. 315-24 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Immunotherapy 100%
  • Vaccination 90%
  • Colorectal Neoplasms 90%
  • Tumor Escape 50%
  • Adoptive Transfer 43%
  20 Citationer (Scopus)

• Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

  Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Moerch Froesig, T., Munir, S., Hadrup, S. R., Andersen, M. H. & Svane, I. M., okt. 2012, I: Cancer Immunology, Immunotherapy. 61, 10, s. 1791-1804 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cyclophosphamide 100%
  • Dendritic Cells 96%
  • Interleukin-2 95%
  • Melanoma 88%
  • Vaccination 85%
  88 Citationer (Scopus)

• Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

  Munir, S., Larsen, S. K., Iversen, T. Z., Donia, M., Klausen, T. W., Svane, I. M., Straten, P. T. & Andersen, M. H., 23 apr. 2012, I: P L o S One. 7, 4, s. e34568

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • indoleamine 2,3-dioxygenase 100%
  • T-cells 87%
  • Indoleamine-Pyrrole 2,3,-Dioxygenase 80%
  • T-lymphocytes 53%
  • T-Lymphocytes 36%
  35 Citationer (Scopus)

• Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

  Junker, N., Kvistborg, P., Køllgaard, T., Straten, P. T., Andersen, M. H. & Svane, I. M., 2012, I: Cellular Immunology. 273, 1, s. 1-9 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Neoplasm Antigens 83%
  • Squamous Cell Carcinoma of Head and Neck 65%
  • Melanoma 49%
  • T-Lymphocytes 48%
  19 Citationer (Scopus)
• 2011

  Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

  Junker, N., Andersen, M. H., Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., Von Buchwald, C., Andersen, E., Straten, P. T. & Svane, I. M., aug. 2011, I: Cytotherapy. 13, 7, s. 822-34 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Adoptive Transfer 90%
  • Squamous Cell Carcinoma of Head and Neck 87%
  • T-Lymphocytes 48%
  • T-Cell Antigen Receptor 16%
  27 Citationer (Scopus)

• Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

  Junker, N., Andersen, M. H., Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., Buchwald, C. V., Andersen, E., Straten, P. T., Svane, I. M. & Andersen, M. H., aug. 2011, I: Cytotherapy. 13, 7, s. 822-34

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Adoptive Transfer 90%
  • Squamous Cell Carcinoma of Head and Neck 87%
  • T-Lymphocytes 48%
  • T-Cell Antigen Receptor 16%
  27 Citationer (Scopus)

• Cell culture plastics with immobilized interleukin-4 for monocyte differentiation

  Hansen, M., Hjortø, G. M., Met, Ö., Jakobsen, M. H., Svane, I. M. & Larsen, N., feb. 2011, I: Journal of Biomedical Materials Research. Part A. 96, 2, s. 372-83 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cell culture 100%
  • Dendritic Cells 86%
  • Amines 61%
  • Plastics 56%
  • Adsorption 50%

• Cell culture plastics with immobilized interleukin-4 for monocyte differentiation

  Hansen, M., Hjortø, G. M., Met, O., Jakobsen, M. H., Svane, I. M. & Larsen, N. B., feb. 2011, I: Journal of Biomedical Materials Research. Part A. 96, 2, s. 372-83 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cell culture 100%
  • Dendritic Cells 86%
  • Amines 61%
  • Plastics 56%
  • Adsorption 50%

• Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

  Bjoern, J., Brimnes, M. K., Andersen, M. H., Straten, P. T. & Svane, I. M., mar. 2011, I: Scandinavian Journal of Immunology. 73, 3, s. 222-33 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Regulatory T-Lymphocytes 100%
  • Dendritic Cells 90%
  • Interleukin-2 89%
  • Melanoma 83%
  • Vaccination 80%
  16 Citationer (Scopus)

• Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

  Junker, N., Thor Straten, P., Andersen, M. H. & Svane, I. M., 2011, I: Journal of Skin Cancer. 2011, 574695, 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Melanoma 65%
  • Clinical Trials 20%
  • Adoptive Transfer 18%
  • Neoplasm Antigens 16%

• Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip

  Selmeczi, D., Hansen, T., Met, Ö., Svane, I. M. & Larsen, N., apr. 2011, I: Biomedical Microdevices. 13, 2, s. 383-92 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dendritic Cells 100%
  • Electroporation 94%
  • Polymers 53%
  • Stainless Steel 52%
  • Stainless steel 38%
  10 Citationer (Scopus)

• Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip

  Selmeczi, D., Hansen, T. S., Met, O., Svane, I. M. & Larsen, N. B., apr. 2011, I: Biomedical Microdevices. 13, 2, s. 383-92 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dendritic Cells 100%
  • Electroporation 94%
  • Polymers 53%
  • Stainless Steel 52%
  • Stainless steel 38%

• High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

  Met, Ö., Balslev, E., Flyger, H. & Svane, I. M., 1 jan. 2011, I: Breast Cancer Research and Treatment. 125, 2, s. 395-406 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dendritic Cells 100%
  • Breast Neoplasms 71%
  • Messenger RNA 63%
  • T-Lymphocytes 41%
  • Neoplasm Antigens 23%
  26 Citationer (Scopus)

• Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

  Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, I. M., Becker, J. C., thor Straten, P. & Andersen, M. H., feb. 2011, I: Cancer Immunology, Immunotherapy. 60, 2, s. 227-34 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cyclin B1 100%
  • HLA-A2 Antigen 73%
  • Epitopes 64%
  • Tissue Donors 59%
  • Peptides 48%
  6 Citationer (Scopus)

• Increase in circulating CD4CD25Foxp3 T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

  Riley, C. H., Morten Krogh, J., Brimnes, M. K., Straten, P. T., Svane, I. M., Hasselbalch, H. C. & Bjerrum, O. W., 25 aug. 2011, I: Blood. 118, 8, s. 2170-2173 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Hydroxyurea 100%
  • Antitumor 63%
  • Donor 46%
  • T-Lymphocytes 42%
  • Confidence Intervals 27%
  52 Citationer (Scopus)

• Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

  Riley, C. H., Jensen, M. K., Brimnes, M. K., Hasselbalch, H. C., Bjerrum, O. W., Straten, P. T. & Svane, I. M., 25 aug. 2011, I: Blood. 118, 8, s. 2170-3 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Hydroxyurea 100%
  • Antitumor 63%
  • Donor 46%
  • T-Lymphocytes 42%
  • Confidence Intervals 27%
  52 Citationer (Scopus)

• Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

  Sørensen, R. B., Hadrup, S. R., Svane, I. M., Hjortsø, M. C., Thor Straten, P., Andersen, M. H., Hjortsø, M. C. & Andersen, M. H., 17 feb. 2011, I: Blood. 117, 7, s. 2200-10 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Indoleamine-Pyrrole 2,3,-Dioxygenase 100%
  • Effector 80%
  • T-Lymphocytes 45%
  • Antigen 30%
  • Donor 25%
  84 Citationer (Scopus)

• Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2

  Sørensen, R. B., Køllgaard, T., Andersen, R. S., van den Berg, J. H., Svane, I. M., Straten, P. T. & Andersen, M. H., 15 mar. 2011, I: Cancer Research. 71, 6, s. 2038-44 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Indoleamine-Pyrrole 2,3,-Dioxygenase 100%
  • T-Lymphocytes 45%
  • tryptophan methyl ester 41%
  • Neoplasms 23%
  • Stereoisomerism 17%
  38 Citationer (Scopus)

• Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients

  Pedersen, A. E., Stryhn, A., Justesen, S., Harndahl, M., Rasmussen, S., Donskov, F., Claesson, M. H., Pedersen, J. W., Wandall, H. H., Svane, I. M. & Buus, S., nov. 2011, I: Journal of Immunotherapy. 34, 9, s. 629-40 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T-Lymphocytes 100%
  • Antibodies 89%
  • Peptides 85%
  • HLA-A Antigens 66%
  • Neoplasms 52%
  10 Citationer (Scopus)
• 2010

  Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

  Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, M. H., Svane, I. M. & Andersen, M. H., 2010, I: Journal of Immunotherapy. 33, 8, s. 876-877 2 s.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

  Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, M. H., Svane, I. M. & Andersen, M. H., 2010, I: Journal of Immunotherapy. 33, 8, s. 876 1 s.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

  Tsakiri, A., Tsiantoulas, D., Frederiksen, J. & Svane, I. M., 1 feb. 2010, I: Experimental Neurology. 221, 2, s. 320-8 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Optic Neuritis 100%
  • Simvastatin 93%
  • Dendritic Cells 70%
  • Monocytes 65%
  • Antigen-Presenting Cells 49%
  13 Citationer (Scopus)

• Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DRâ¿»/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

  Bidragets oversatte titel: Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DRâ¿»/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myelomaBrimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. & Svane, I. M., 2010, I: Scandinavian Journal of Immunology. 72, 6, s. 540-7

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

  Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. & Svane, I. M., 1 dec. 2010, I: Scandinavian Journal of Immunology. 72, 6, s. 540-7 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Myeloid-Derived Suppressor Cells 100%
  • HLA-DR Antigens 81%
  • Regulatory T-Lymphocytes 74%
  • Multiple Myeloma 74%
  • Dendritic Cells 67%
  154 Citationer (Scopus)

• Increase of Circulating CD4(+)CD25(high)Foxp3(+) Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2

  Bidragets oversatte titel: Increase of Circulating CD4(+)CD25(high)Foxp3(+) Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2Berntsen, A., Brimnes, M. K., Straten, P. T., Svane, I. M., Berntsen, A., Brimnes, M. K., Straten, P. T. & Svane, I. M., 2010, I: Journal of Immunotherapy. 33, 4, s. 425-434 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2

  Berntsen, A., Brimnes, M. K., thor Straten, P. & Svane, I. M., maj 2010, I: Journal of Immunotherapy. 33, 4, s. 425-34 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Regulatory T-Lymphocytes 100%
  • Renal Cell Carcinoma 96%
  • Dendritic Cells 90%
  • Interleukin-2 89%
  • Vaccination 80%
  38 Citationer (Scopus)

• Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial

  Schmidt, H., Brown, J., Mouritzen, U., Selby, P., Fode, K., Svane, I. M., Cook, G. P., Mollerup, D. H. & Geertsen, P. F., 1 nov. 2010, I: Clinical Cancer Research. 16, 21, s. 5312-9 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • interleukin-21 100%
  • Renal Cell Carcinoma 69%
  • Melanoma 60%
  • Safety 42%
  • Maximum Tolerated Dose 21%
  30 Citationer (Scopus)

• Therapeutic cancer vaccines

  Larsen, S. K., Svane, I. M., Straten, P. T. & Andersen, M. H., 2010, I: Current Cancer Therapy Reviews. 6, 2, s. 163-174

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cancer Vaccines 100%
  • Neoplasms 26%
  • Therapeutics 13%
  • Vaccination 13%
  • Immune System 13%
  2 Citationer (Scopus)

• Therapeutic cancer vaccines in combination with conventional therapy

  Andersen, M. H., Junker, N., Ellebaek, E., Svane, I. M., Thor Straten, P. & Andersen, M. H., 1 jan. 2010, I: Journal of Biomedicine and Biotechnology. 2010, s. 237623

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cancer Vaccines 100%
  • Protein 34%
  • Combination Drug Therapy 20%
  • Neoplasms 19%
  • Immunotherapy 18%
  24 Citationer (Scopus)

• Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

  Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, M. H., Svane, I. M. & Andersen, M. H., 2010, I: Journal of Immunotherapy. 33, 8, s. 919-920 2 s.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

  Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, M. H., Pedersen, A. E., Soleimani, A., Lorentzen, T., Johansen, J. S. & Svane, I. M., 1 okt. 2010, I: Cytotherapy. 12, 6, s. 721-34 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Neoplasm Antigens 100%
  • Dendritic Cells 84%
  • Melanoma 77%
  • Vaccination 75%
  • HLA-A2 Antigen 36%
  63 Citationer (Scopus)
• 2009

  Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function

  Trepiakas, R., Pedersen, A. E., Met, O. & Svane, I. M., 2009, I: Vaccine. 27, 16, s. 2213-9 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • interferon-alpha 100%
  • dendritic cells 97%
  • Interferon-alpha 73%
  • Dendritic Cells 66%
  • Up-Regulation 53%
  27 Citationer (Scopus)

• CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53

  Sørensen, R. B., Andersen, R. S., Svane, I. M., Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, M. H. & thor Straten, P., 2009, I: Clinical Cancer Research. 15, 5, s. 1543-9 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cyclin B1 100%
  • Breast Neoplasms 48%
  • T-Lymphocytes 46%
  • Peptides 34%
  • Neoplasms 24%
  12 Citationer (Scopus)

• Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

  Andersen, M. H., Sørensen, R. B., Brimnes, M. K., Svane, I. M., Becker, J. C. & thor Straten, P., 2009, I: Journal of Clinical Investigation. 119, 8, s. 2245-56 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Heme Oxygenase-1 100%
  • Regulatory T-Lymphocytes 84%
  • T-Lymphocytes 52%
  • CD8 Antigens 29%
  • Neoplasms 27%
  58 Citationer (Scopus)